Botanix Pharma Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 1
Employees
  • Stock Symbol
  • BOT
Stock Symbol
  • Share Price
  • $0.08
  • (As of Friday Closing)

Botanix Pharma General Information

Description

Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • PO Box 1407
  • Subiaco, Western Australia 6904
  • Australia
+61 (08) 0000 0000

Botanix Pharma Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Botanix Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.08 $0.09 $0.01 - $0.14 $78.8M 973M 5.09M

Botanix Pharma Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 78,991 9,421 85,950 42,134
Revenue 7
EBITDA (6,218) (11,225) (12,264) (8,596)
Net Income (6,239) (11,207) (12,183) (8,530)
Total Assets 20,560 17,392 3,642 13,010
Total Debt 243 289 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Botanix Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Botanix Pharma‘s full profile, request access.

Request a free trial

Botanix Pharma Executive Team (6)

Name Title Board Seat Contact Info
Richard Peterson Chief Financial Officer
H. William Bosch Executive Director & Chief Scientific Officer
Howie McKibbon Chief Commercial Officer
Stephane Levy Chief Medical Officer
Vince Ippolito President & Executive Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Botanix Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial